Cargando…

Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells

Activation of the signal transducer and activator of transcription 3 (STAT3) is observed in multiple cancer types, including gastric cancer, and represents a potential drug target for chemotherapy. Currently, clinically available small-molecule inhibitors targeting STAT3 are lacking. Here, we report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hailun, Hong, Huang, Zhang, Lulu, Cai, Xiong, Hu, Meng, Cai, Yuepiao, Zhou, Bin, Lin, Jiayuh, Zhao, Chengguang, Hu, Wanle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677376/ https://www.ncbi.nlm.nih.gov/pubmed/29138596 http://dx.doi.org/10.2147/CMAR.S146173

Ejemplares similares

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
por: Bai, Encheng, et al.
Publicado: (2018)

Bacterial Vaginosis, Atopobium vaginae and Nifuratel
por: Polatti, Franco
Publicado: (2012)

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
por: Shi, Lingyi, et al.
Publicado: (2017)

Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2020)

Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway
por: Kang, Yanting, et al.
Publicado: (2016)

Nifuratel reduces Salmonella survival in macrophages by extracellular and intracellular antibacterial activity
por: Xie, Tian, et al.
Publicado: (2023)

Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
por: Zhuang, Yan, et al.
Publicado: (2019)

Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis
por: Melcon-Fernandez, Estela, et al.
Publicado: (2023)

Drug repositioning of anti-microbial agent nifuratel to treat mast cell-mediated allergic responses
por: Lee, Ji Eon, et al.
Publicado: (2023)

Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells
por: Zhao, Chengguang, et al.
Publicado: (2015)

Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression
por: Liu, Yanan, et al.
Publicado: (2020)

Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021)

LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
por: Zuo, Mingxin, et al.
Publicado: (2015)

Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
por: Couto, Jason I, et al.
Publicado: (2012)

Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019)

Discovery of a Novel MyD88 Inhibitor M20 and Its Protection Against Sepsis-Mediated Acute Lung Injury
por: Song, Jiali, et al.
Publicado: (2021)

Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors
por: Brotherton-Pleiss, Christine, et al.
Publicado: (2020)

Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12
por: Bid, Hemant K., et al.
Publicado: (2012)

Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway
por: Yang, Lehe, et al.
Publicado: (2020)

Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling
por: Yan, Sunshun, et al.
Publicado: (2023)

A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
por: Lin, Li, et al.
Publicado: (2010)

Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro
por: Kim, Yu-Jin, et al.
Publicado: (2020)

LLL12B, a Novel Small-Molecule STAT3 Inhibitor, Induces Apoptosis and Suppresses Cell Migration and Tumor Growth in Triple-Negative Breast Cancer Cells
por: Pan, Li, et al.
Publicado: (2022)

DRUG-REPOSITIONING SCREENING IDENTIFIED PIPERLONGUMINE AS A DIRECT STAT3 INHIBITOR WITH POTENT ACTIVITY AGAINST BREAST CANCER
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Potent and specific MTH1 inhibitors targeting gastric cancer
por: Zhou, Wenjuan, et al.
Publicado: (2019)

Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease
por: Li, Lingyu, et al.
Publicado: (2022)

Star-Shaped Poly(furfuryl glycidyl ether)-Block-Poly(glyceryl glycerol ether) as an Efficient Agent for the Enhancement of Nifuratel Solubility and for the Formation of Injectable and Self-Healable Hydrogel Platforms for the Gynaecological Therapies
por: Ziemczonek, Piotr, et al.
Publicado: (2021)

Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer
por: Li, Haobin, et al.
Publicado: (2022)

Correction: Potent and specific MTH1 inhibitors targeting gastric cancer
por: Zhou, Wenjuan, et al.
Publicado: (2020)

An integrated strategy for identifying new targets and inferring the mechanism of action: taking rhein as an example
por: Sun, Hao, et al.
Publicado: (2018)

Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages
por: Hu, Lulu, et al.
Publicado: (2017)

lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance
por: Cai, Mao, et al.
Publicado: (2021)

Sanguinarine exhibits potent efficacy against cervical cancer cells through inhibiting the STAT3 pathway in vitro and in vivo
por: Zhang, Huijuan, et al.
Publicado: (2019)

Curcumin: A Potent Protectant against Esophageal and Gastric Disorders
por: Kwiecien, Slawomir, et al.
Publicado: (2019)

Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T‐cell lymphoma
por: Wang, Yali, et al.
Publicado: (2023)

Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer
por: Zhao, Chengwei, et al.
Publicado: (2019)

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway
por: Lee, Jen-Chieh, et al.
Publicado: (2022)

The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
por: Ball, Sarah, et al.
Publicado: (2011)

A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin
por: Zhang, Ruijie, et al.
Publicado: (2021)

Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity
por: Wang, Yingying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0358mamqm2hvbbpjrtmrj69hv6